CRT 2024

Panel Discussion: Innovative Technology Headwinds and Tailwinds

Panel Moderator(s)

• 

  Andrew Farb, MD

  Chief Medical Officer, Office of Cardiovascular Devices
  U.S. Food and Drug Administration
  Silver Spring, Maryland, United States

  No relationships to disclose
• 

  Aaron V. Kaplan, MD, FSCAI, FACC, FNAI

  Professor of Medicine
  Dartmouth Health Geisel School of Medicine at Dartmouth
  Lebanon, New Hampshire, United States

  Disclosure information not submitted.
• 

  Mitchell Krucoff, MD, FACC

  Professor Medicine/Cardiology
  Duke University Medical Center/Duke Clinical Research Institute
  Durham, North Carolina, United States

  Disclosure information not submitted.

Panel Discussant(s)

• 

  Dorothy B. Abel, BSBME

  Partner
  Abel and Wolf Consulting
  Santa Rosa, California, United States

  Disclosure(s): Abel and Wolf Consulting: Consultant (Ongoing)
• 

  Steven Farmer, MD, PhD

  Chief Strategy Officer
  CMS
  Baltimore , Maryland, United States

  No relationships to disclose
• 

  Chip Hance, BS, MBA

  CEO
  Regatta Medical
  Bannockburn, Illinois, United States

  No relationships to disclose
• 

  Katherine Kumar, PhD, RAC

  Sr. EVP
  4C Medical Technologies, Inc.
  Minnetonka, Minnesota, United States

  Disclosure information not submitted.
• 

  April Marrone

  FDA/CDRH TAP Advisor
  FDA/CDRH

  Disclosure(s): No financial relationships to disclose
• 

  Charles A. Simonton, MD, FACC, FSCAI

  EVP Chief Medical Officer
  Abiomed Inc
  Charlotte, North Carolina, United States

  Disclosure information not submitted.
• 

  Changfu Wu, PhD

  SBRBPAS Expert
  Food and Drug Administration
  Silver Spring, Maryland, United States

  Disclosure(s): No financial relationships to disclose